"We are currently accepting new patients. Please, reach out if you have any questions regarding our visit. There may be COVID restrictions for this facility. We appreciate you considering our team to provide you with the most compassionate care available."

During the past decade, CHI Saint Vincent Cancer Center Hot Springs conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 41 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 37 clinical trials were completed. i.e. 66.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHI Saint Vincent Cancer Center Hot Springs" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHI Saint Vincent Cancer Center Hot Springs" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "CHI Saint Vincent Cancer Center Hot Springs" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Recurrent Ovarian Carcinoma" (6 trials). Many other conditions were trialed in "CHI Saint Vincent Cancer Center Hot Springs" in a lesser frequency.

Most popular intervention types in "CHI Saint Vincent Cancer Center Hot Springs" are "Drug" (121 trials), "Other" (88 trials), "Biological" (71 trials), "Procedure" (47 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (29 trials), "Nivolumab" (27 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "CHI Saint Vincent Cancer Center Hot Springs" are 125 trials for "All" genders, 25 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "CHI Saint Vincent Cancer Center Hot Springs". undefined are not yet recruiting, 54 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CHI Saint Vincent Cancer Center Hot Springs, 2 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CHI Saint Vincent Cancer Center Hot Springs, 3 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".